does wellmark cover glp-1 drugs Episode 7: Cutting pharmacy spend with biosimilars News
Description
Novo expects an approval decision from the U.S
Label status: In January 2025, the Ozempic label was updated to state that it is not recommended in patients with severe gastroparesis, but does not indicate that the drug itself may cause the condition
Early research suggests patches might lower some gastrointestinal side effects by releasing medication more steadily, but this has not been confirmed in human studies
(2024) 47:S2042
Purpose-built for physicians Tirzepatide linked to lower risk for death, adverse CV and kidney outcomes vs
For instance, one study employing accelerometer-based assessments of gravitational load demonstrated that patients who lost weight following gastric bypass experienced a drop of 2 215 kN/d in cumulative daily loading within the first month, despite increased step counts
